{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:32:12Z","timestamp":1790724732930,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068601","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T20:59:33Z","timestamp":1373489973000},"page":"e68601","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Overexpression of GATA1 Confers Resistance to Chemotherapy in Acute Megakaryocytic Leukemia"],"prefix":"10.1371","volume":"8","author":[{"given":"John Timothy","family":"Caldwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Dombkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry H.","family":"Matherly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10428199509075307","article-title":"Acute Megakaryoblastic Leukemia","volume":"18","author":"W Gassmann","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10428199309148552","article-title":"Acute Megakaryoblastic Leukemia in Children and Adolescents: A Retrospective Analysis of 24 Cases","volume":"10","author":"RC Ribeiro","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood.V97.12.3727","article-title":"Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution\u2019s experience","volume":"97","author":"UH Athale","year":"2001","journal-title":"Blood"},{"key":"ref4","article-title":"Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children\u2019s Oncology Group Study POG","author":"MM O\u2019Brien","year":"2012"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1182\/blood.V80.9.2210.2210","article-title":"Acute myeloid leukemia (AML) in Down\u2019s syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498","volume":"80","author":"Y Ravindranath","year":"1992","journal-title":"Blood"},{"key":"ref6","first-page":"608","article-title":"Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children\u2019s Cancer Group Studies 2861 and 2891","volume":"91","author":"BJ Lange","year":"1998","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2003.08.060","article-title":"Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children\u2019s Cancer Group Study 2891","volume":"21","author":"AS Gamis","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0145-2126(94)90111-2","article-title":"Myelodysplasia and acute megakaryoblastic leukemia in Down\u2019s syndrome","volume":"18","author":"A Zipursky","year":"1994","journal-title":"Leuk Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome","volume":"32","author":"J Wechsler","year":"2002","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcdb.2004.11.002","article-title":"GATA1 in normal and malignant hematopoiesis","volume":"16","author":"JD Crispino","year":"2005","journal-title":"Semin in Cell & Amp; Dev Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2004-03-1154","article-title":"Gene expression profiling of pediatric acute myelogenous leukemia","volume":"104","author":"ME Ross","year":"2004","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajh.21332","article-title":"Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia","volume":"84","author":"RM Ayala","year":"2009","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V86.8.3173.3173","article-title":"The expression pattern of erythrocyte\/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia","volume":"86","author":"T Shimamoto","year":"1995","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.coi.2007.06.002","article-title":"Life and death during hematopoietic differentiation","volume":"19","author":"JT Opferman","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7878471","article-title":"Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice","volume":"267","author":"N Motoyama","year":"1995","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/blood.V94.1.87.413k41_87_96","article-title":"GATA-1 and Erythropoietin Cooperate to Promote Erythroid Cell Survival by Regulating bcl-xL Expression","volume":"94","author":"T Gregory","year":"1999","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/MCB.02212-06","article-title":"GATA-1 and Gfi-1B interplay to regulate Bcl-xL transcription","volume":"27","author":"YY Kuo","year":"2007","journal-title":"Mol Cell Biol"},{"key":"ref18","first-page":"1393","article-title":"Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin","volume":"94","author":"JW Taub","year":"1999","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/dji026","article-title":"GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia","volume":"97","author":"Y Ge","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mcp.2005.09.008","article-title":"Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes","volume":"20","author":"A Mogal","year":"2006","journal-title":"Mol Cell Probes"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1158\/1078-0432.CCR-10-1707","article-title":"Mechanisms of Synergistic Antileukemic Interactions between Valproic Acid and Cytarabine in Pediatric Acute Myeloid Leukemia","volume":"16","author":"C Xie","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2008-09-179812","article-title":"RUNX1 regulates phosphoinositide 3-kinase\/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia","volume":"114","author":"H Edwards","year":"2009","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2002-07-2337","article-title":"Transcriptional regulation of the cystathionine-\u03b2-synthase gene in Down syndrome and non\u2013Down syndrome megakaryocytic leukemia cell lines","volume":"101","author":"Y Ge","year":"2003","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.leu.2405066","article-title":"The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy","volume":"22","author":"Y Ge","year":"2007","journal-title":"Leukemia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/bioinformatics\/btg202","article-title":"A comparison of statistical methods for analysis of high density oligonucleotide array data","volume":"19","author":"D Rajagopalan","year":"2003","journal-title":"Bioinformatics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2005-06-2219","article-title":"Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia","volume":"107","author":"Y Ge","year":"2006","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/0008-5472.CAN-03-2456","article-title":"The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines","volume":"64","author":"Y Ge","year":"2004","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bcp.2010.11.011","article-title":"Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway","volume":"81","author":"S Chateauvieux","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"W Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"W Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/cdd.2012.88","article-title":"Mcl-1 and Bcl-xL regulate Bak\/Bax-dependent apoptosis of the megakaryocytic lineage at multistages","volume":"19","author":"T Kodama","year":"2012","journal-title":"Cell Death Differ"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2008-02-137943","article-title":"Phase I study of obatoclax mesylate (GX15-070), a small molecule pan\u2013Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia","volume":"113","author":"SM O\u2019Brien","year":"2009","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1158\/1078-0432.CCR-08-0999","article-title":"A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies","volume":"14","author":"AD Schimmer","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e17138","DOI":"10.1371\/journal.pone.0017138","article-title":"Inhibition of Histone Deacetylases 1 and 6 Enhances Cytarabine-Induced Apoptosis in Pediatric Acute Myeloid Leukemia Cells","volume":"6","author":"X Xu","year":"2011","journal-title":"PLOS ONE"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1172\/JCI60455","article-title":"Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome","volume":"122","author":"S Malinge","year":"2012","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/sj.leu.2402174","article-title":"CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis","volume":"15","author":"D Raspadori","year":"2001","journal-title":"Leukemia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/leu.2008.46","article-title":"Association between high expression of natural killer related-genes (NCAM\/CD94) and early death during induction in children with acute myeloid leukemia","volume":"22","author":"L Lonigro","year":"2008","journal-title":"Leukemia"},{"key":"ref38","article-title":"Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis","author":"B Guo","year":"2012"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood-2009-06-230474","article-title":"Leukemia regression by vascular disruption and antiangiogenic therapy","volume":"116","author":"GJ Madlambayan","year":"2010","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3324\/haematol.2011.040535","article-title":"Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia","volume":"96","author":"I V\u00e1zquez","year":"2011","journal-title":"Haematologica"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/1097-0142(20000601)88:11<2529::AID-CNCR14>3.0.CO;2-S","article-title":"The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia: an overview of 2483 patients from 22 studies","volume":"88","author":"Y Kanda","year":"2000","journal-title":"Cancer"},{"key":"ref42","article-title":"CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation","author":"HH Zhu","year":"2013"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1470-2045(11)70326-6","article-title":"Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial","volume":"13","author":"M Pfirrmann","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","article-title":"Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia","volume":"25","author":"A Quint\u00e1s-Cardama","year":"2011","journal-title":"Leukemia"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T10:46:25Z","timestamp":1596105985000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068601"}},"subtitle":[],"editor":[{"given":"Yves","family":"St-Pierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068601","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}